269 related articles for article (PubMed ID: 29875776)
1. Endothelial Dysfunction in Kidney Transplantation.
Cardinal H; Dieudé M; Hébert MJ
Front Immunol; 2018; 9():1130. PubMed ID: 29875776
[TBL] [Abstract][Full Text] [Related]
2. Anti-LG3 Antibodies Aggravate Renal Ischemia-Reperfusion Injury and Long-Term Renal Allograft Dysfunction.
Yang B; Dieudé M; Hamelin K; Hénault-Rondeau M; Patey N; Turgeon J; Lan S; Pomerleau L; Quesnel M; Peng J; Tremblay J; Shi Y; Chan JS; Hébert MJ; Cardinal H
Am J Transplant; 2016 Dec; 16(12):3416-3429. PubMed ID: 27172087
[TBL] [Abstract][Full Text] [Related]
3. Ischaemia-reperfusion injury: a major protagonist in kidney transplantation.
Ponticelli C
Nephrol Dial Transplant; 2014 Jun; 29(6):1134-40. PubMed ID: 24335382
[TBL] [Abstract][Full Text] [Related]
4. Ischemic Conditioning in Kidney Transplantation.
Veighey K; MacAllister R
J Cardiovasc Pharmacol Ther; 2017 Jul; 22(4):330-336. PubMed ID: 28395520
[TBL] [Abstract][Full Text] [Related]
5. Non-HLA antibodies against endothelial targets bridging allo- and autoimmunity.
Dragun D; Catar R; Philippe A
Kidney Int; 2016 Aug; 90(2):280-288. PubMed ID: 27188505
[TBL] [Abstract][Full Text] [Related]
6. The Endothelial Glycocalyx as a Target of Ischemia and Reperfusion Injury in Kidney Transplantation-Where Have We Gone So Far?
Duni A; Liakopoulos V; Koutlas V; Pappas C; Mitsis M; Dounousi E
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671524
[TBL] [Abstract][Full Text] [Related]
7. Analysis of dendritic cells and ischemia-reperfusion changes in postimplantation renal allograft biopsies may serve as predictors of subsequent rejection episodes.
Batal I; Mohan S; De Serres SA; Vasilescu ER; Tsapepas D; Crew RJ; Patel SS; Serban G; McCune K; Husain SA; Chang JH; Herter JM; Bhagat G; Markowitz GS; D'Agati VD; Hardy MA; Ratner L; Chandraker A
Kidney Int; 2018 May; 93(5):1227-1239. PubMed ID: 29544662
[TBL] [Abstract][Full Text] [Related]
8. The 20S proteasome core, active within apoptotic exosome-like vesicles, induces autoantibody production and accelerates rejection.
Dieudé M; Bell C; Turgeon J; Beillevaire D; Pomerleau L; Yang B; Hamelin K; Qi S; Pallet N; Béland C; Dhahri W; Cailhier JF; Rousseau M; Duchez AC; Lévesque T; Lau A; Rondeau C; Gingras D; Muruve D; Rivard A; Cardinal H; Perreault C; Desjardins M; Boilard É; Thibault P; Hébert MJ
Sci Transl Med; 2015 Dec; 7(318):318ra200. PubMed ID: 26676607
[TBL] [Abstract][Full Text] [Related]
9. The effect of ischemia/reperfusion on the kidney graft.
Menke J; Sollinger D; Schamberger B; Heemann U; Lutz J
Curr Opin Organ Transplant; 2014 Aug; 19(4):395-400. PubMed ID: 24905021
[TBL] [Abstract][Full Text] [Related]
10. Renal ischemia--reperfusion injury: an inescapable event affecting kidney transplantation outcome.
Böhmová R; Viklický O
Folia Microbiol (Praha); 2001; 46(4):267-76. PubMed ID: 11830936
[TBL] [Abstract][Full Text] [Related]
11. The determinants, biomarkers, and consequences of microvascular injury in kidney transplant recipients.
Doreille A; Dieudé M; Cardinal H
Am J Physiol Renal Physiol; 2019 Jan; 316(1):F9-F19. PubMed ID: 30379097
[TBL] [Abstract][Full Text] [Related]
12. Ischemia and reperfusion injury in renal transplantation: hemodynamic and immunological paradigms.
Requião-Moura LR; Durão Junior Mde S; Matos AC; Pacheco-Silva A
Einstein (Sao Paulo); 2015; 13(1):129-35. PubMed ID: 25993079
[TBL] [Abstract][Full Text] [Related]
13. Renal urokinase-type plasminogen activator (uPA) receptor but not uPA deficiency strongly attenuates ischemia reperfusion injury and acute kidney allograft rejection.
Gueler F; Rong S; Mengel M; Park JK; Kiyan J; Kirsch T; Dumler I; Haller H; Shushakova N
J Immunol; 2008 Jul; 181(2):1179-89. PubMed ID: 18606671
[TBL] [Abstract][Full Text] [Related]
14. Injury derived autoimmunity: Anti-perlecan/LG3 antibodies in transplantation.
Dieudé M; Cardinal H; Hébert MJ
Hum Immunol; 2019 Aug; 80(8):608-613. PubMed ID: 31029511
[TBL] [Abstract][Full Text] [Related]
15. Bone marrow-derived endothelial progenitor cells and endothelial cells may contribute to endothelial repair in the kidney immediately after ischemia-reperfusion.
Kwon O; Miller S; Li N; Khan A; Kadry Z; Uemura T
J Histochem Cytochem; 2010 Aug; 58(8):687-94. PubMed ID: 20354148
[TBL] [Abstract][Full Text] [Related]
16. Nontransgenic hyperexpression of a complement regulator in donor kidney modulates transplant ischemia/reperfusion damage, acute rejection, and chronic nephropathy.
Pratt JR; Jones ME; Dong J; Zhou W; Chowdhury P; Smith RA; Sacks SH
Am J Pathol; 2003 Oct; 163(4):1457-65. PubMed ID: 14507653
[TBL] [Abstract][Full Text] [Related]
17. [Pathophysiology of ischemia-reperfusion injury in renal transplantation].
Boratyńska M; Kamińska D; Mazanowska O
Postepy Hig Med Dosw (Online); 2004 Feb; 58():1-8. PubMed ID: 15069377
[TBL] [Abstract][Full Text] [Related]
18. Endothelial Cells in Antibody-Mediated Rejection of Kidney Transplantation: Pathogenesis Mechanisms and Therapeutic Implications.
Wang S; Zhang C; Wang J; Yang C; Xu M; Rong R; Zhu T; Zhu D
J Immunol Res; 2017; 2017():8746303. PubMed ID: 28255564
[TBL] [Abstract][Full Text] [Related]
19. Novel cardiolipin therapeutic protects endothelial mitochondria during renal ischemia and mitigates microvascular rarefaction, inflammation, and fibrosis.
Liu S; Soong Y; Seshan SV; Szeto HH
Am J Physiol Renal Physiol; 2014 May; 306(9):F970-80. PubMed ID: 24553434
[TBL] [Abstract][Full Text] [Related]
20. Endothelial transcripts uncover a previously unknown phenotype: C4d-negative antibody-mediated rejection.
Sis B; Halloran PF
Curr Opin Organ Transplant; 2010 Feb; 15(1):42-8. PubMed ID: 20009933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
